617 results
Page 2 of 31
8-K
57qy3
2 Feb 24
Bristol Myers Squibb Reports Fourth Quarter and Full-Year Financial Results for 2023
7:46am
SC TO-T
EX-99
ksjts2p
25 Jan 24
Third party tender offer statement
8:13am
SC TO-T
EX-99
j2ml5cie sfj7
25 Jan 24
Third party tender offer statement
8:13am
SC TO-T
EX-99
hesgrx0
25 Jan 24
Third party tender offer statement
8:13am
SC TO-T
EX-99
rclaj9rvkkxd67t qglz
25 Jan 24
Third party tender offer statement
8:13am
SC TO-C
EX-99.2
8yot1
26 Dec 23
Information about tender offer
4:22pm
SC TO-C
EX-99.5
kcj6 2cpmi4
26 Dec 23
Information about tender offer
4:22pm
SC TO-C
EX-99.1
oujmrmb6 nda8
26 Dec 23
Information about tender offer
4:22pm
SC TO-C
EX-99.4
admy97222ks0ix qq
26 Dec 23
Information about tender offer
4:22pm
SC TO-C
6bofjp75bhjmyfeoppe3
26 Dec 23
Information about tender offer
4:22pm
SC TO-C
EX-99.3
7e4h1cq66sj
26 Dec 23
Information about tender offer
4:22pm
DFAN14A
22pt7jg5cc
22 Dec 23
Additional proxy materials by non-management
4:36pm
DFAN14A
72m8gm
22 Dec 23
Additional proxy materials by non-management
4:21pm
DFAN14A
EX-99.1
zj63xxlo
22 Dec 23
Additional proxy materials by non-management
4:21pm
8-K
EX-99.1
3otfhxn7brg2xhn1v
22 Dec 23
Bristol Myers Squibb Strengthens Neuroscience Portfolio with Acquisition of Karuna Therapeutics
4:15pm
8-K
yqwb79ac
22 Dec 23
Bristol Myers Squibb Strengthens Neuroscience Portfolio with Acquisition of Karuna Therapeutics
4:15pm
8-K
fyhk4oj5jldair
26 Oct 23
Bristol Myers Squibb Reports Third Quarter Financial Results for 2023
7:44am
8-K
EX-99.1
tg11k 9bw8
26 Oct 23
Bristol Myers Squibb Reports Third Quarter Financial Results for 2023
7:44am
DFAN14A
s3fkx5eoohi
10 Oct 23
Additional proxy materials by non-management
6:48am